430 related articles for article (PubMed ID: 15553071)
1. [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
Halota W; Pawłowska M
Przegl Epidemiol; 2002; 56 Suppl 5():41-5. PubMed ID: 15553071
[TBL] [Abstract][Full Text] [Related]
2. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
3. [Coinfection with HIV and HCV--epidemiologic, diagnostic, clinical and therapeutic implications].
Jabłonowska E
Przegl Epidemiol; 2004; 58(4):621-8. PubMed ID: 15810503
[TBL] [Abstract][Full Text] [Related]
4. The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.
Jevtović Dj; Ranin J; Salemović D; Pesić I; Dragović G; Zerjav S; Djurković-Djaković O
Biomed Pharmacother; 2008 Jan; 62(1):21-5. PubMed ID: 17223307
[TBL] [Abstract][Full Text] [Related]
5. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
6. [HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges].
Laufer NL; Quarleri JF; Bouzas MB; Perez HM; Salomon H; Cahn PE
Medicina (B Aires); 2007; 67(1):82-91. PubMed ID: 17408028
[TBL] [Abstract][Full Text] [Related]
7. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
[TBL] [Abstract][Full Text] [Related]
8. Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.
Pineda JA; Macías J
J Antimicrob Chemother; 2005 Apr; 55(4):417-9. PubMed ID: 15731202
[TBL] [Abstract][Full Text] [Related]
9. Grade 3-4 liver enzyme elevation during HAART in HIV and hepatitis C co-infected adults.
Yunihastuti E; Gani RA; Lesmana LA; Sundaru H; Djauzi S
Acta Med Indones; 2009 Jul; 41(3):130-5. PubMed ID: 19752485
[TBL] [Abstract][Full Text] [Related]
10. Liver ultrastructural morphology and mitochondrial DNA levels in HIV/hepatitis C virus coinfection: no evidence of mitochondrial damage with highly active antiretroviral therapy.
Matsukura M; Chu FF; Au M; Lu H; Chen J; Rietkerk S; Barrios R; Farley JD; Montaner JS; Montessori VC; Walker DC; Côté HC
AIDS; 2008 Jun; 22(10):1226-9. PubMed ID: 18525271
[TBL] [Abstract][Full Text] [Related]
11. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
Macías J; Melguizo I; Fernández-Rivera FJ; García-García A; Mira JA; Ramos AJ; Rivera JM; Pineda JA
Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):775-81. PubMed ID: 12461586
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
Petoumenos K; Ringland C;
HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
[TBL] [Abstract][Full Text] [Related]
14. [HIV and HCV infections--clinical implications].
Pawłowska M; Halota W; Grabczewska E
Przegl Epidemiol; 2004; 58 Suppl 1():71-5. PubMed ID: 15807161
[TBL] [Abstract][Full Text] [Related]
15. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups.
Weissbrich B; Langmann P; Schubert J; Jassoy C; Klinker H
Eur J Med Res; 2003 Nov; 8(11):495-8. PubMed ID: 14644704
[TBL] [Abstract][Full Text] [Related]
16. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.
Vallet-Pichard A; Pol S
J Hepatol; 2006; 44(1 Suppl):S28-34. PubMed ID: 16343684
[TBL] [Abstract][Full Text] [Related]
17. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection.
Cooper CL; Mills E; Angel JB
AIDS; 2007 Jan; 21(1):71-6. PubMed ID: 17148970
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic interventions for HIV infection and chronic viral hepatitis.
Cooper CL
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
[TBL] [Abstract][Full Text] [Related]
20. Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy.
Tuma P; Medrano J; Resino S; Vispo E; Madejón A; Sánchez-Piedra C; Rivas P; Labarga P; Martín-Carbonero L; Barreiro P; Soriano V
Antivir Ther; 2010; 15(6):881-6. PubMed ID: 20834100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
